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Background: The time course of progressive dilatation of the right ventricle (RV) in adults with pulmonary
regurgitation (PR) late after repair of tetralogy of Fallot (TOF) is poorly characterized.
Methods:We analysed cardiac MRI data (1.5 T) from 14 adult repaired TOF patients (26± 11 years of age)with
dilated RVs and known signiﬁcant PR, on 2 separate visits with a between MRI period of 2.1 ± 1.0 years.
Results: Indexed RV end diastolic volume (RVEDVi) increased over 2 years (142 ± 19 to 151 ± 20 mL/m2, p=
0.005; change = 8.4 ± 9.3 mL/m2, range =−6 to 26 mL/m2; annual mL/m2 increase = 4.3 ± 4.6; annual
percentage increase= 3.1 ± 3.3%), whilst RV ejection fraction decreased (53 ± 8 to 49± 7 %, p= 0.039).
RV muscular corpus (RVMC) EDVi signiﬁcantly increased (130 ± 19 to 138 ± 20 mL/m2, p = 0.014),
whereas RV outﬂow tract (RVOT) EDVi did not (12 ± 7 vs 13 ± 6 mL/m2, p = 0.390). No other RV or
LV measures signiﬁcantly changed during the inter-MRI period. The change in RVEDVi correlated signif-
icantly with LV end diastolic volume (r=−0.582, p= 0.029), RVEDVi:LVEDVi (r= 0.6, p= 0.023) and
RVMC EDVi (r = 0.9, p b 0.001) but not RVOT EDVi (r = 0.225, p = 0.459).
Conclusions: Adult repaired TOF patients with free PR experienced a mean 3.1%, or 4.3 mL/m2, annual in-
crease in RVEDVi, unrelated to the initial RVEDVi or PR fraction. The increase in RVEDVi was due to RVMC
rather than RVOT dilatation. This provides a guide to the frequency of MR surveillance and insights into
the natural history of progressive RV dilatation in this setting.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Long standing pulmonary regurgitation (PR) is a common occur-
rence after the repair of tetralogy of Fallot (TOF) due to pulmonary
valve excision and/or the frequent use of transannular patch during ini-
tial repair of the right ventricular outﬂow tract. Exposure of the right
ventricle (RV) to a chronic regurgitant load leads to RV dilatation and
has been associated with negative consequences such as exercise intol-
erance, arrhythmia and sudden cardiac death [1–7].
RV dilatation in themoderate to severe range is frequently observed
in young adult life in repaired TOF patients, at which point replacement, Royal Prince Alfred Hospital,
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eliability and freedom from bias
and Ltd. This is an open access articleof the pulmonary valve (PVR) is considered. Pulmonary valve replace-
ment has been shown to be safe and effective in reducing PR, RV dilata-
tion and QRS duration [8–15]. However, controversy surrounds the
degree to which the RV should be “allowed to dilate” before the need
for surgical intervention. Many centres advocate a conservative ap-
proach of performing surgery when indexed RV end-diastolic volume
(RVEDVi) reaches 150 mL/m2. However, there is some evidence that
the RV can be allowed to dilate to as large as 170 mL/m2 [10,11] whilst
still achieving normalisation of RV volume after PV replacement
(RVEDVi ≤108 mL/m2 [16]). PVR timing is based on these RV volumet-
ric cut-points, yet the progression of RV dilatation towards these mile-
stones is poorly understood. Furthermore, the contributions of RV
muscular corpus (RVMC) and RV outﬂow tract (RVOT) volumes in the
temporal changes of global RV dilatation have yet to be investigated.
Two recent reports have suggested only slow if any progression of RV
volumes in this clinical context [17,18]. We therefore sought to charac-
terize temporal changes in global RV, RVOT and RVMC volumes in TOF




Age (years) 26 ± 11
Males (n) 7
Age at TOF repair (years) 3.2 ± 2.9
Years between TOF repair and 1st MRI 23 ± 8
TOF indicates tetralogy of Fallot.
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2.1. Patient population
140 adult repaired TOF patients had undergone cardiac MRI in our
imaging facility; 69 subsequently underwent PVR or percutaneous pul-
monary valve implantation (PPVI). Of the remaining 71 patients who
had not undergone surgical or percutaneous procedure to implant a
pulmonary valve, 14 had 1 or more follow up cardiac MRIs. Data was
used in these 14 patients referred for 2 clinically indicated cardiac
MRIs, and if more than 2 scans had been undertaken, the greatest
inter-MRI period was chosen. Overall, the inter-cardiac MRI period
was 2.1±1.0 years. Ethics approvalwas obtained from the Royal Prince
Alfred Hospital Human Research Ethics Committee, Sydney, and all par-
ticipants gave informed consent.
2.2. Cardiovascular MRI protocol
MRI was performed using a 1.5 T MR scanner (GE medical system).
2.2.1. Assessment of ventricular volumes and function using cine MRI
4 chamber and short axis views covering both ventricles (9–12
slices) were acquired in the vertical long-axis using retrospectively
gated steady-state free precession (FIESTA) cine MR images. Image
parameters: TR = 3.2 ms; TE = 1.6 ms; ﬂip angle = 78˚; slice
thickness = 8 mm; matrix = 192 × 256; ﬁeld of view-300–380 mm;
and temporal resolution = 40 ms, acquired during a breath-hold. As-
sessments of RV and LV volumeswere performed bymanual segmenta-
tion of short-axis cine images with endocardial outline at end diastole
and end systole (performed in Osirix software, version 4.0 32 bit).
Regional analysis of the RV volumes in systole and diastole was then
performed, where the RV was divided in the ﬁbrous RVOT and RVMC
components. The delineation of these segments was based on the fol-
lowing criteria. The ﬁbrous RVOT was contoured from the pulmonary
valve leaﬂets superiorly, to the ﬁbrous to muscular transition zone
with in the RVOT anteriorly based on delayed enhancement studies.
Posteriorly the ﬁbrous RVOT was contoured to include volume until
the superior aspect of the interventrcular septum. An arbitrary line
was contoured between the lower anterior and posterior landmarks
to deﬁne the lower border zone of the ﬁbrous RVOT. Fibrous RVOT
measurements were independently analysed in all subjects by two
observers with an intraclass correlation coefﬁcient of 0.977 for end-
systolic measurements and 0.923 for end diastolic measurements.
Simpson's rule was used to calculate end-diastolic and end-systolic
volumes for both ventricles and the RVOT; ejection fractions (EF) were
calculated from these volumes.
2.2.2. MR ﬂow calculation
A phase sensitive (VENC 200) gradient-echo sequence (TR, b5 ms;
TE, b3 ms; ﬂip angle, 15˚; slice thickness, 7 mm; ﬁeld of view = 300–
380 mm matrix, 256 × 240, temporal resolution = 30 ms) during
breath hold was used to acquire pulmonary artery (PA) and aortic
ﬂow data. The midpoint of the main PA and ascending aorta (sino-
tubular junction) were used as imaging planes. Through-plane ﬂow
data was acquired by use of retrospective cardiac gating. Phase contrast
images were used to calculate arterial blood ﬂow by use of a semiauto-
matic vessel edge-detection algorithm (Reportcard, 4.0, GE,Milwaukee)
with manual operator correction. Net forward ﬂow within the main PA
(mL) and PR fraction (%) were calculated as total PA ﬂow minus back-
ward PA ﬂow, and percent backward PA ﬂow over total PA ﬂow,
respectively. These calculations were similarly made for the aortic ﬂow.
2.2.3. Late gadolinium enhancement: scar/ﬁbrosis imaging
Segmented phase-sensitive inversion recovery sequences (Image
parameters: TR = 2 × RR interval; TE = 3.4 ms; ﬂip angle = 25°;
slice thickness = 10 mm; matrix = 144 × 256; ﬁeld of view = 300–380 mm, acquired during a single breath-hold) were used to identify
myocardial scar 10 min post-administration of intravenous contrast
(0.2 mmol/kg of gadolinium pentatate, Magnevist). There entire short
and long-axis of the LV and RV.2.3. Statistical methods
All data are presented asmean± SD. Statistical comparison of initial
and follow upMRI data was performed with a 2-tailed paired Student t
tests. The pre-speciﬁed primary study endpoint was change in RVEDVi.
As other endpoints were inter-related and the study was exploratory in
nature, p-values were not adjusted for multiple comparisons. Pearson's
correlation coefﬁcient was used to assess relations between change in
RVEDVi and other MRI variables. Inter-observer variability in RVOT
volume analysis was assessed via interclass correlation. Statistical
signiﬁcance was inferred at a two-tailed p-value b0.05. Statistical
analyses were performed with SPSS V.21 for Windows (SPSS).3. Results
3.1. Patient population (n = 14)
Cardiac MRI data was included from 14 patients (age at evaluation
26 ± 11 years; mean age at repair 3.2 ± 2.9 years; 7 males). Patient
demographics and surgical details are outlined in Table 1. TOF was the
primary diagnosis and a trans-annular patch repair had been performed
in all 14 patients.3.2. MRI results (n = 14)
MRI results are displayed in Table 2. Initially, the cohort had
moderate RV dilatation (indexed RV end-diastolic volume [RVEDVi];
142 ± 19 mL/m2, indexed RV end-systolic volume [RVESVi]; 68 ±
17mL/m2), moderate to severe PR (PR fraction; 33 ± 11%) and normal
RV ejection fraction (RVEF; 53 ± 8%). Indexed LV end-diastolic volume
(LVEDVi; 76 ± 10 mL/m2) and LV ejection fraction (LVEF; 61 ± 5%)
were within normal ranges, however, LV end-systolic volume was
mildly elevated (LVESVi; 30 ± 7 mL/m2). LV and RV stroke volumes
(SV) were maintained (LVSV; 82 ± 15 mL, RVSV; 132 ± 21 mL).
RVOT volume was 8.6 ± 4.6% of RV volume (indexed RVOT end-
diastolic volume [RVOT EDVi]; 12 ± 7 mL/m2).
After 2.1 ± 1.0 years, RVEDVi had increased signiﬁcantly (to 151 ±
20 mL/m2, p = 0.005; change = 8.4 ± 9.3 mL/m2, range = −6
to 26 mL/m2; annual mL/m2 increase = 4.3 ± 4.6; annual percentage
increase = 3.1 ± 3.3%). RVESVi (77 ± 19 mL/m2, p = 0.009) and
RVMC indexed end-diastolic volume (RVMC EDVi; 138 ± 20 mL/m2,
p = 0.014) also increased, and RVEF decreased (49 ± 7%, p= 0.039).
RVEDVi increased from below to above an RVEDVi of 150 mL/m2 in 3
patients (see Fig. 1). No other RV or LV structural or functionalmeasures
signiﬁcantly changed in the period between MRIs.
Change in RVEDVi was signiﬁcantly correlated with initial LVEDVi
(r=−0.582, p= 0.029), initial RVEDVi:LVEDVi (r=0.6, p= 0.023)
and change in RVMC EDVi (r = 0.919, p b 0.001) but not change in
RVOT EDVi (r= 0.182, p= 0.552) (see Fig. 2).
Table 2
Cardiac MRI values at initial and follow up MRI.
MRI 1 MRI 2 Change
RVEDVi (mL/m2) 142 ± 19 151 ± 20⁎ 8.4 ± 9.3
RVESVi (mL/m2) 68 ± 17 77 ± 19⁎ 9.2 ± 11.3
RVMC EDVi (mL/m2) 130 ± 19 138 ± 20⁎ 7.6 ± 9.5
RVOT EDVi (mL/m2) 12 ± 7 13 ± 6 0.4 ± 1.7
RVSV (mL) 132 ± 21 132 ± 23 0.1 ± 13.8
RVEF (%) 53 ± 8 49 ± 7⁎ −3.6 ± 5.8
RVCO (L) 9.0 ± 1.3 9.0 ± 1.6 0.0 ± 1.4
PRF (%) 33 ± 11 33 ± 12 0.3 ± 4.4
RV:LV ratio 1.9 ± 0.3 1.9 ± 0.3 0.0 ± 0.2
LVEDVi (mL/m2) 76 ± 10 79 ± 11 3.0 ± 7.2
LVESVi (mL/m2) 30 ± 7 31 ± 7 1.1 ± 5.7
LVSV (mL) 82 ± 15 85 ± 15 3.3 ± 11.2
LVEF (%) 61 ± 5 60 ± 5 −1.1 ± 4.4
LVCO (L) 5.6 ± 0.6 5.8 ± 1.1 0.2 ± 1.1
⁎ indicates p b 0.05; EDVi indicates indexed end-diastolic volume; ESVi, end-systolic
volume; RVMC, RV muscular corpus; RVOT, RV outﬂow tract; SV, stroke volume; EF,
ejection fraction; CO, cardiac output; PRF, pulmonary regurgitant fraction.
Fig. 2. Correlation of change in RVEDVi with change in RVMC EDV.
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In our cohort of adult repaired TOF patientswith free PR, RV volumes
signiﬁcantly increased over 2 years, from 5% below the commonly used
RVEDVi indicator for PVR of 150 mL/m2 to marginally above this cut-
point. The observed RV dilatationwas related to RVMC volume enlarge-
ment but not change in RVOT size, initial RVEDVi or initial PR fraction.
In addition to RV dilatation, RVEF signiﬁcantly decreased during the
inter-MRI period.
The natural history of RV dilatation in repaired TOF has not been
thoroughly studied. Our results are in contrast to previous reports
which did not show a signiﬁcant increase in RV size or deterioration of
RV function over a similar period of time [17,18]. There was some vari-
ation in the degree of change in RV size, with 3 patients experiencing
approximately up to 25 mL/m2 increase in RVEDVi and 3 patients
exhibitingminimal change in serial RV volumes. The RV dilated moder-
ately in the remaining 8 patients. This variation can, to some extent,
be explained by the degree to which the RVMC dilated. We showed
that those patients with greater RVMC dilatation experienced greater
increase in global RV size.
Progression of RV size is important in this setting, as it has signiﬁcant
implications for the timing of PVR and imaging follow up periods. Spe-
ciﬁcally, rapid RV dilatation may warrant early surgical intervention
and short follow up periods. Early PVR may have the advantage of
preventing the potentially damaging effects of an enlarged RV [9,19].
However, reintervention due to limited valve lifespan [20,21] requires
consideration, particularly in asymptomatic patients.Fig. 1. Right ventricular volume at ﬁrst and second MRI.4.1. Study limitations
This study was limited by the small number of patients and the
relatively short time frame over which they were followed. There is
also the possibility of selection bias from patients with echocardio-
graphic evidence of a dilating RV being referred for cardiac MRI. Larger,
long-term prospective studies are required to better understand
progression of RV dilatation and its determinants throughout the
lifespan of TOF patients.
5. Conclusions
The RV continues to dilate in many patients with PR late after TOF
repair, approximately 5–10% over 2 years. These data might inform a
reasonable interval for serial MRI scanning, especially given the inaccu-
racy of cardiac ultrasound for precise measurements of RV volumes.
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